This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Saved Citations Download to citation manager Request Permissions Request Reprints Add to My Marked Citations Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Citing Articles via Scopus Google Scholar Articles by Dursun, S.M. Articles by Kutcher, S.P. Search for Related Content PubMed PubMed Citation Articles by Dursun, S.M. Articles by Kutcher, S.P. Social Bookmarking                   What's this?

High-dose vitamin E plus vitamin B6 treatment of risperidone-related neuroleptic malignant syndrome

Department of Psychiatry, Psychopharmacology Unit, Dalhousie University, Halifax, Nova Scotia, Canada

O.J. Oluboka

Department of Psychiatry, Psychopharmacology Unit, Dalhousie University, Halifax, Nova Scotia, Canada

S. Devarajan

Department of Psychiatry, Psychopharmacology Unit, Dalhousie University, Halifax, Nova Scotia, Canada

S.P. Kutcher

Department of Psychiatry, Psychopharmacology Unit, Dalhousie University, Halifax, Nova Scotia, Canada

We present a case of a 74-year-old patient with schizoaffective disorder, who developed risperidone-related neurleptic malignant syndrome. This patient responded satisfactorily to the supportive management and vit E plus vit B6.

Key Words: neuroleptic malignant syndrome • risperidone • vitamin B6 • vitamin E

Journal of Psychopharmacology, Vol. 12, No. 2, 220-221 (1998)
DOI: 10.1177/026988119801200214


CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				D. L Stevens Association Between Selective Serotonin-Reuptake Inhibitors, Second-Generation Antipsychotics, and Neuroleptic Malignant Syndrome Ann. Pharmacother., September 1, 2008; 42(9): 1290 - 1297. [Abstract] [Full Text] [PDF]